Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis a 20-year followup study
✍ Scribed by Charles D. Radis; Leslie E. Kahl; Gary L. Baker; Mary Chester Morgan Wasko; Joseph M. Cash; Aileen Gallatin; Bertrand L. Stolzer; Amrit K. Agarwal; Thomas A. Medsger Jr; C. Kent Kwoh
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 831 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To investigate the efficacy and safety of leflunomide beyond 2 years in a multinational, open‐label extension of 2 phase III double‐blind studies. ## Methods Patients with rheumatoid arthritis (RA) who received leflunomide (100 mg/day for 3 days, 10 mg/day or 20 mg/day t
## Abstract ## Objective To investigate whether cognitive–behavioral therapy (CBT) administered early in the course of rheumatoid arthritis (RA) has long‐term effects on health care use. ## Methods We reviewed the files of 47 of the original 53 patients with early RA who volunteered for a random
## Abstract ## Objective To identify activity limitation in early rheumatoid arthritis (RA) to detect patients needing assistive devices. To evaluate the effects of assistive devices. ## Methods A multicenter cohort of 284 early RA patients was examined using the Evaluation of Daily Activity Que